Please assess the completion status of the following clinical trial:

Trial Title: Open Label, Continuation Study of Cholic Acid in Subjects With Inborn Errors of Bile Acid Synthesis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~Subjects who received cholic acid through CCHMC protocols 91-10-10 or CAC-002-01 and meet the following criteria are eligible for study participation.~1. The subject and/or parent/legal guardian must have provided informed consent prior to study start.~2. The subject must have a diagnosis of an inborn error of bile acid synthesis.~3. The subject must be willing and able to comply with all study assessments and procedures.~4. Subjects with other organ dysfunction will not be excluded

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cholic Acid (Type: OTHER): Active drug

Based on this trial design, predict the completion outcome and termination type (if applicable).